To analyze estrogen and progesterone receptors (ER, PR) 
Introduction
About 90% of cases of DUB are anovulatory and 10% ovulatory 1 . During an anovulatory cycle, the corpus luteum does not form. Thus, the normal cyclical secretion of progesterone does not occur, and estrogen stimulates the endometrium unopposed 2 . Without progesterone, the endometrium continues to proliferate, eventually outgrowing its blood supply; it then sloughs and bleeds incompletely, irregularly, and sometimes profusely or for a long time. When this abnormal process occurs repeatedly, the endometrium can become hyperplastic, sometimes with atypical or cancerous cells 3 . Anovulatory DUB can result secondary to PCOS and hypothyroidism 4 . An acute bleeding episode is best controlled with high-dose estrogen. Treatment of chronic, repetitive, bleeding problems may consist of hormonal therapy with estrogen and progestin or cyclical progestin alone. Surgery may be needed if hormone therapy fails. Surgical options include dilation and curettage (D&C), laser or electrocauterization, endometrial ablation, or hysterectomy 4 . Circulating blood levels of estrogen and progesterone have implications on DUB 7 . A few studies have shown that DUB has high estradiol levels 8 . The estrogen receptor (ER) and progesterone receptor (PR) expression and distribution pattern might play an important role in normal endometrial function. Receptor studies in DUB cases show that ER and PR levels in DUB patients were significantly higher 8 . Morphometric analysis included gland shape, lumen/gland relative volume, gland: stroma ratio and number of capillaries/mm 2 stroma 9 . In this study we have evaluated the histopathological features of endometrium in correlation with hormone levels and with special emphasis on receptors and morphometry in the diagnosis of menorrhagia.
II. Material And Methods
The present study is a one year prospective study carried out in our hospital. The material for the present study was collected from patients who attended Department of Obstetrics and Gynecology and diagnosed clinically to have dysfunctional uterine bleeding. The selection criteria included a meticulous examination to rule out any known cause of excessive bleeding, thus strictly adhering to the definition of DUB. All the patients were subjected to Ultra sonogram to rule out any known pathology. Dilatation and curettage was done under local anesthesia and material sent for histopathological study with complete clinical details. The same day blood was collected for estradiol estimation. Serum estradiol levels were estimated by Immunoflorescence technique. The histopathology report was then correlated with the estradiol levels. Estimation of ER & PR receptors were done using leica reagents. Morphometric analysis of glands and stroma were done with appropriate controls. The results of histopathology, LMP, Estradiol levels, special stains and ER, PR receptors were correlated and analyzed to conclude the cause of menorrhagia. The analyzed data was compared with other series in literature and discussed. The data is tabulated and analysed using Chi-Square test. P value of <0.05 is considered as statistically significant.
III. Results
The study was conducted on 60 patients clinically diagnosed as DUB. The age group of these patients ranged from 22 years to 60 years with maximum number of cases in the range of 31 to 40 years (54.1%). Only 5.8% were found to be more than 50 years. The common symptom is menorrhagia with 53.3%. Dilatation and curettage was performed on 84% of patients. The common histopathologic diagnosis being proliferative phase in 40% and Disordered proliferative endometrium in 13.3%. Of these 41.6% and 75% did not correlate with LMP respectively. Secretory enodometrium was seen in 31.6%. in the age group of 25-45yrs. 60% did not correlate with LMP. Irregular ripening was seen in 3.3 % of patients in the age group of 35-40 yrs. Simple cystic hyperplasia was seen in 10% of the patients in the age group of 35-52yrs. Complex hyperplasia was seen in 1.6%. Estradiol levels are markedly increased in complex hyperplasia with more than 120pg/ml, in simple endometrial hyperplasia and disordered proliferation of endometrium majority had estradiol levels in the range of 81-100pg/dl. Estrogen receptor levels in stroma and glands was given separate scores based on positivity (0-25% = 1, 26-50% = 2, 51-75% = 3, 76-100% = 4) and the sum of the both scores obtained was expressed. Progesterone receptor in stroma and glands was given separate scores based on positivity (0-25% = 1, 26-50% = 2, 51-75% = 3, 76-100% = 4) and the sum of the both scores obtained was expressed. Mitotic index (0-5 =1+, 6-10=2+, 11-15=3+, 16-20=4+ and >20=5+) was increased in disordered proliferation, simple endometrial hyperplasia and very high in complex endometrial hyperplasia and endometrial carcinoma. Gland: stroma ratio was very high in simple endometrial hyperplasia, complex endometrial hyperplasia and endometrial carcinoma. The most common glands seen were cylindrical. Simple endometrial hyperplasia, complex endometrial hyperplasia and endometrial carcinoma had ramified glands. Simple endometrial hyperplasia, complex endometrial hyperplasia and endometrial carcinoma had increased lumen/gland relative volume and showed increased number capillaries/mm 2 stroma.
IV. Discussion
Menstrual disorders are common, accounting for almost 3% of all outpatient referrals and over 20% of referrals to gynecology outpatients' clinics. 1 In this study the maximum age incidence of patients suffering from menorrhagia was between 31-40 years. Pilli In this study serum estradiol levels were high in simple endometrial hyperplasia and complex endometrial hyperplasia and very high in endometrial carcinoma. Vysotskiĭ MM et al 8 reported high estradiol levels were detected in the blood sera of patients with glandular cystic polyps, atypical and glandular hyperplasia. Gorchev G 9 et al found normal and decreased estradiol levels in atypical hyperplasia and endometrial carcinoma. Lépine J et al 10 stated that circulating levels of estradiol levels were significantly higher in endometrial carcinoma compared to normal endometrium. Mülayim B 11 et al reported serum estradiol levels were significantly higher in perimenopausal women with menometrorrhagia. Moen MH 12 et al stated that estradiol levels are increased in perimenopausal women with menometrorrhagia.
In this study PAS stain didn't show any advantage when compared to H & E. Hong Yul Choi 13 et al reported that secretory substance in the epithelial cells of the endometrial glands during the secretory phase and menstrual phase was mainly glycogen and concluded that PAS staining is superior to routine hematoxylin and eosin staining for the detection of epithelial secretory substance. Eddie SM 14 et al stated that PAS stain is superior to H & E.
In this study mitotic index, gland: stroma ratio, lumen/gland relative volume and number of capillaries/mm2 stroma were increased in simple, complex endometrial hyperplasia and endometrial carcinoma. Dunton C 15 et al reported that simple endometrial hyperplasia have few mitoses, increased number of glands relative to stroma. In complex endometrial hyperplasia mitoses are typically present; the gland-to-stroma ratio is higher compared to simple hyperplasia. Kendal BS 16 et al stated that endometrial carcinoma showed high gland: stroma ratio and increased mitoses. Elyzabeth Avvad 17 et al reported that volume density was greater in simple hyperplasia than in proliferative endometrium. In simple hyperplasia the glands usually have a tendency to be crowded and with great diameters (luminal dilatation). Baak 18 et al stated that volume density decreases in atypical hyperplasia and well-differentiated adenocarcinoma of the endometrium.
In this study ER and PR levels were increased in hyperplasias and endometrial carcinomas. 
V. Conclusion
An imbalance of the hormones leads to abnormal uterine bleeding and also endometrial carcinoma. In our study ER and PR levels were very high in simple and complex endometrial hyperplasia & endometrial carcinoma. It was slightly increased in disordered proliferation and irregular shedding and almost normal in secretory and proliferative endometrium. Thus ER and PR levels shown to be increased in endometrial carcinomas have been associated with well differentiated tumor phenotype and treatment options are determined on the basis of their levels. Finally stepwise evidence -based approach to managing menorrhagia is recommended. Medical management is considered first line in the treatment of menorrhagia. Oral contraceptive pills, patches, vaginal rings, cyclic progestins or levonorgestrel IUD may be utilized to regulate menses. When medical management fails, surgical options that may be considered include operative hysteroscopy with endometrial resection, endometrial ablation, uterine artery embolization or hysterectomy.
